Skip to main content
. 2013 Sep 25;49(8):1253–1263. doi: 10.1007/s00535-013-0884-0

Table 1.

Baseline characteristics of the patients

Factor Value (range or number)
Chronic hepatitis (n = 209) Liver cirrhosis (n = 60) PSE or splenectomy (n = 30)
Sex (male/female) (cases) 90/119 35/25 16/14
Mean age/range (years) 57.9 ± 11.2 62.7 ± 9.2 61.0 ± 7.1
White blood cells (/mm3) 4,648.8 ± 1,613.8 4,068.3 ± 1,156.2 3,410.4 ± 1,268.3a
Hemoglobin (g/dl) 13.8 ± 1.5 13.2 ± 1.6 12.5 ± 2.2a
Platelet count (×104/mm3) 16.2 ± 4.9 11.2 ± 3.0 6.0 ± 1.4a
AST (IU/l) 47.2 ± 32.4 77.2 ± 47.1 58.0 ± 24.2a
ALT (IU/l) 57.9 ± 51.8 82.3 ± 58.9 54.8 ± 24.9a
AST/ALT 0.94 ± 0.29 1.01 ± 0.25 1.12 ± 0.30a
Total bilirubin (mg/dl) 0.8 ± 0.3 0.9 ± 0.4 1.2 ± 0.5a
Albumin (g/dl) 4.1 ± 0.3 3.8 ± 0.4 3.7 ± 0.5a
PT percentage activity (%) 94.6 ± 10.0 83.5 ± 8.9 80.6 ± 13.2a
Associated esophageal varices (cases) (present/absent) 0/209 42/18 18/12
History of treatment for HCC (cases) (with or without) 9/200 19/41 6/24
Previous treatment of IFN (cases) with or without) 81/128 30/30 24/6
HCV genotype (1b/2a/2b/2a + 2b/2a or 2b) (cases) 153/31/22/3/0 50/6/3/0/1 25/4/1/0/0
HCV-RNA (KIU/ml)
 100 ≤ HCV-RNA < 1,000 KIU/ml (cases) 64 19 10
 ≥1,000 KIU/ml (cases) 145 41 20
Amino acid substitutions in the HCV genotype 1b (n = 153) (n = 50) (n = 25)
 Core aa 70 [arginine/glutamine (histidine)/ND] 92/49/12 22/26/2 12/13/0
 Core aa 91 (leucine/methionine/ND) 95/46/12 35/13/2 19/6/0
ISDR of NS5A in the HCV genotype 1b (n = 153) (n = 50) (n = 25)
(Wild type/non-wild type/ND) 117/23/13 38/9/3 22/3/0
Genetic variation near IL28B gene(rs 8099917) in patients with genotype 1b (n = 153) (n = 50) (n = 25)
 (TT/TG/GG/ND) 81/42/4/26 29/17/1/3 16/9/0/0

AST Aspartate aminotransferase, ALT alanine aminotransferase, AST/ALT aspartate aminotransferase/alanine aminotransferase ratio, ND not determined

aWe excluded two patients who had already undergone splenectomy in other hospitals because we could not obtain their data before splenectomy